Target Pharmasolutions, Inc.
Clinical trials sponsored by Target Pharmasolutions, Inc., explained in plain language.
-
Long-Term PBC study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study followed 711 adults with primary biliary cholangitis (PBC) for 5 years to learn how the disease is managed in everyday medical practice. Researchers collected data on treatments, lab results, and side effects, and also stored blood samples for future genetic research. …
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:53 UTC
-
Scientists track COVID-19 in 199 patients to uncover key patterns
Knowledge-focused CompletedThis study watched 199 adults hospitalized with COVID-19 to learn more about the disease. Researchers collected information on patient backgrounds, treatments used, and how the illness progressed over time. The goal was to answer important questions about COVID-19 that were still…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:50 UTC
-
Massive study tracks fatty liver disease to guide future treatments
Knowledge-focused CompletedThis study followed over 7,300 people with nonalcoholic fatty liver disease (NAFLD) or its more severe form, NASH, in regular medical clinics. The goal was to learn how the disease progresses over time and how doctors currently treat it, since there are no approved medications. T…
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC